AstraZeneca_NN
Annual_JJ
Report_NN
and_CC
96_CD
Form_NN
20-F_JJ
Information_NOMZ
2005_CD
NOTES_NN
TO_PIN
THE_DT
FINANCIAL_NN
STATEMENTS_NOMZ
CONTINUED_VBD
7_CD
PROPERTY_NN
,_,
PLANT_NN
AND_PHC
EQUIPMENT_NOMZ
Assets_NN
in_PIN
Total_NN
Land_NN
and_PHC
Plant_NN
and_PHC
course_NN
of_PIN
tangible_JJ
buildings_GER
equipment_NOMZ
construction_NOMZ
assets_NN
$_$
m_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
Cost_NN
At_PIN
1_CD
January_NN
2003_CD
3,145_CD
6,612_CD
1,298_CD
11,055_CD
Capital_NN
expenditure_NN
67 215 964_CD
1,246_CD
Transfer_NN
of_PIN
assets_NN
into_PIN
use_NN
510_CD
915_CD
1,425_CD
Disposals_NN
and_CC
other_JJ
movements_NOMZ
42_CD
667_CD
22_CD
731_CD
Exchange_NN
adjustments_NOMZ
448 906 133_CD
1,487_CD
At_PIN
31_CD
December_NN
2003_CD
4,128_CD
7,981_CD
948_CD
13,057_CD
Capital_NN
expenditure_NN
17 205 851_CD
1,073_CD
Transfer_NN
of_PIN
assets_NN
into_PIN
use_NN
430_CD
641_CD
1,071_CD
Disposals_NN
and_CC
other_JJ
movements_NOMZ
55_CD
335_CD
6_CD
396_CD
Exchange_NN
adjustments_NOMZ
281_CD
590_CD
45_CD
916_CD
At_PIN
31_CD
December_NN
2004_CD
4,801_CD
9,082_CD
767_CD
14,650_CD
Capital_NN
expenditure_NN
13 150 669 832_CD
Transfer_NN
of_PIN
assets_NN
into_PIN
use_NN
257 594 851_CD
Disposals_NN
and_CC
other_JJ
movements_NOMZ
99_CD
820_CD
14_CD
933_CD
Exchange_NN
adjustments_NOMZ
482_CD
971_CD
91_CD
1,544_CD
At_PIN
31_CD
December_NN
2005_CD
4,490_CD
8,035_CD
480_CD
13,005_CD
Depreciation_NOMZ
At_PIN
1_CD
January_NN
2003_CD
895_CD
3,555_CD
4,450_CD
Charge_NN
for_PIN
year_NN
150 840 990_CD
Disposals_NN
and_CC
other_JJ
movements_NOMZ
35 553 588_CD
Exchange_NN
adjustments_NOMZ
129 529 658_CD
At_PIN
31_CD
December_NN
2003_CD
1,139_CD
4,371_CD
5,510_CD
Charge_NN
for_PIN
year_NN
172 749 921_CD
Impairment_NOMZ
31_CD
31_CD
Disposals_NN
and_CC
other_JJ
movements_NOMZ
37 302 339_CD
Exchange_NN
adjustments_NOMZ
86 344 430_CD
At_PIN
31_CD
December_NN
2004_CD
1,360_CD
5,193_CD
6,553_CD
Charge_NN
for_PIN
year_NN
166 799 965_CD
Impairment_NOMZ
90_CD
90_CD
Disposals_NN
and_CC
other_JJ
movements_NOMZ
53 794 847_CD
Exchange_NN
adjustments_NOMZ
153 588 741_CD
At_PIN
31_CD
December_NN
2005_CD
1,320_CD
4,700_CD
6,020_CD
Net_JJ
book_NN
value_NN
At_PIN
31_CD
December_NN
2003_CD
2,989_CD
3,610_CD
948_CD
7,547_CD
At_PIN
31_CD
December_NN
2004_CD
3,441_CD
3,889_CD
767_CD
8,097_CD
At_PIN
31_CD
December_NN
2005_CD
3,170_CD
3,335_CD
480_CD
6,985_CD
Impairment_NOMZ
charges_NN
in_PIN
2005_CD
relate_VPRT
to_PIN
the_DT
write-down_NN
of_PIN
assets_NN
associated_VBN [WZPAST]
with_PIN
capacity_NOMZ
reviews_NN
at_PIN
manufacturing_VBG
sites_NN
,_,
primarily_RB
in_PIN
the_DT
UK_NN
and_PHC
France_NN
._.
These_DEMP
were_VBD [PASS]
recognized_VBN [PRIV]
in_PIN
cost_NN
of_PIN
sales_NN
in_PIN
the_DT
income_NN
statement_NOMZ
._.
The_DT
impairment_NOMZ
charge_NN
in_PIN
2004_CD
was_VBD [PASS]
made_VBN
to_TO
write_VB [PUBV]
off_PIN
assets_NN
associated_VBN [WZPAST]
with_PIN
Iressa_NN
._.
This_DEMP
was_VBD [PASS]
recognized_VBN [PRIV]
in_PIN
cost_NN
of_PIN
sales_NN
in_PIN
the_DT
income_NN
statement_NOMZ
._.
Capital_NN
expenditure_NN
in_PIN
the_DT
year_NN
of_PIN
$_$
832m_CD
2004_CD
$_$
1,073_CD
m_NN
,_,
2003_CD
$_$
1,246_CD
m_NN [PASS]
did_VBD
not_XX0
include_VB
any_QUAN
capitalized_VBN
finance_NN
leases_NN
2004_CD
$_$
nil_CD
,_,
2003_CD
$_$
nil_JJ
._.
